TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 2 | 1 | 3 | -1 | 27 | 29 | 9 | 1 | -58 | 1 |
| P | %wins | 33 | 100 | 100 | 100 | 67 | 0 | 67 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/25/22 17:17 | 4/20/22 | CRXT | Clarus Therapeutics Holdings, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Thomas McNerney & Partners LP | MN | T | S.a | -9,495 | 2.53 | 0 | -3,753 | -100 | 4 | I | |||||||||||||||
4/21/22 19:04 | 4/20/22 | CRXT | Clarus Therapeutics Inc | Health | Drug | Pharmaceutical Preparations | Thomas McNerney & Partners LP | MN | T | S | -9,495 | 2.53 | 0 | -3,753 | -100 | 4 | I | ||||||||||||||||
4/6/11 17:01 | 4/6/11 | TZYM | Tranzyme Inc | DE | Health | Drug | Pharmaceutical Preparations | Thomas McNerney & Partners LP | MN | T | P.d | 3,250 | 4.00 | 4 | 813 | 10 | 8,986 | M | 1 | 0 | 0 | 13 | -23 | ||||||||||
11/30/10 12:26 | 11/29/10 | ZGNX | Zogenix, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Thomas McNerney & Partners LP | MN | H | See Foot | P.d | 2,127 | 4.00 | 0 | 532 | 59 | 1,427 | I | -2 | -2 | 48 | 43 | 9 | 11 | -57 | |||||||
11/29/10 21:43 | 11/29/10 | ZGNX | Zogenix, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Thomas McNerney & Partners LP | MN | H | See Foot | P.d | 709 | 4.00 | 0 | 177 | 11 | 1,726 | M | -2 | 34 | 43 | 4 | 15 | -58 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |